TrialSignal
Clinical trial intelligence report
Management Strategies by an Orthopedic Department to Improve the Evaluation and Treatment of Osteoporosis.
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT02239523
Status
COMPLETED
Phase
NA
Sponsor
Shaare Zedek Medical Center
Executive brief
Investment-Ready Snapshot
This clinical trial evaluates the effectiveness of orthopedic interventions in managing osteoporosis in patients with fragility fractures. It aims to improve treatment adherence and conduct a cost-benefit analysis of the interventions. The study was conducted at Shaare Zedek Medical Center and involved 200 patients over 50 years old.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT02239523
Indication
Osteoporotic Fracture
Modality
monoclonal antibody
Target
Osteoporosis management after hip fracture
Intervention
Letter Group, Intervention Group
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.